Aya Nakaya1,18, Takae Kohara2,18, Hirohiko Shibayama2,18, Yoshiyuki Onda3,18, Junya Kanda3,18, Hitomi Kaneko4,18, Kazunori Imada4,18, Toru Kida5,18, Satoru Kosugi5,18, Jun Ishikawa6,18, Ryosuke Yamamura7,18, Yutaka Shimazu8,18, Hirokazu Tanaka9,18, Shinichi Fuchida10,18, Yuji Shimura11,18, Miki Kiyota12,18, Katsuya Wada12,18, Nobuhiko Uoshima13,18, Hideo Yagi14,18, Satoshi Yoshihara15,18, Kensuke Ohta16,18, Chihiro Shimazaki10,18, Masayuki Hino17,18, Akifumi Takaori3,18, Junya Kuroda11,18, Itaru Matsumura9,18, Yuzuru Kanakura2,18, Shosaku Nomura1,18 (1.First Department of Internal Medicine, Kansai Medical University, 2.Osaka University Graduate School of Medicine, 3.Department of Hematology and Oncology, Kyoto University, 4.Department of Hematology, Japanese Red Cross Osaka Hospital, 5.Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, 6.Department of Hematology, Osaka International Cancer Institute, 7.Department of Hematology, Osaka Saiseikai Nakatsu Hospital, 8.Hematol., Japanese Red Cross Wakayama Medical Center, 9.Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, 10.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, 11.Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, 12.Department of Hematology, Matsushita Memorial Hospital, 13.Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, 14.Nara Prefecture General Medical Center, Department of Hematology and Oncology, 15.Hyogo College of Medicine, Department of Internal Medicine, Division of Hematology, 16.Hematology Ohta Clinic, Shinsaibashi, 17.Hematology, Osaka City University Graduate School of Medicine, 18.Kansai Myeloma Forum)
Session information
Oral Session
Oral Session 2-9D Multiple Myeloma: Clinical (Prognosis/Biomarker/Salvage Therapy)
Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.9 (Tokyo International Forum, 4F G402)
Chair: Chikako Ohwada (Department of Hematology, Chiba University Hospital)
Akihiro Kitadate1,2, Toshiki Terao1, Takafumi Tsushima1, Hiroki Kobayashi1, Yoshiaki Abe1, Daisuke Miura1, Kentaro Narita1, Masami Takeuchi1, Naoto Takahashi2, Kosei Matsue1 (1.Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan, 2.Department of Hematology, Nephrology, and Rheumatology. Akita University, Akita, Japan)
Daisuke Miura, Kentaro Narita, Toshiki Terao, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Kameda medical centor, Kamogawa city, Japan)
Junichiro Nashimoto, Kiyoshi Okazuka, Yui Uto, Kota Sato, Kanji Miyazaki, Mizuki Ogura, Yumiko Yoshiki, Yu Abe, Nobuhiro Tsukada, Tadao Ishida, Kenshi Suzuki (Dept. of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)
Anja Seckinger1, Ute Hegenbart1, Susanne Beck1, Martina Emde1, Tilmann Bochtler1, Christoph Kimmich1, Carsten Mueller-Tidow1, Anna Jauch2, Stefan Schoenland1, Dirk Hose1 (1.Heidelberg University Hospital, Heidelberg, BW, Federal Republic of Germany, 2.Heidelberg University, Heidelberg, BW, Federal Republic of Germany)
Nobuhiro Tsukada, Junichiro Nashimoto, Yui Uto, Kota Sato, Kanji Miyazaki, Mizuki Ogura, Yumiko Yoshiki, Yu Abe, Kiyoshi Okazuka, Tadao Ishida, Kenshi Suzuki (Dept. of Hematol., Japanese Red Cross Medical Center, Tokyo, Japan)